Home | Support   Headline News: FDA Fake Drugs Drug Testing	Biopure (BPUR) Reaffirms Strategy Following Recent NIH/FDA Workshop 7 May 08, 14:00 Biopure Corporation (Nasdaq: BPUR) announced that the Company's strategy to pursue indications for its product Hemopure(R) [hemoglobin glutamer-250 ... more

© 2007 nafdacnigeria.org